Do heterozygous and homozygous Factor V Leiden carriers differ regarding risk for incident and recurrent venous thromboembolism? A retrospective cohort study

Published: 9 March 2016
Author(s): J. Perez Botero, W.D. Ormsby, A.A. Ashrani, R.D. McBane, W.E. Wysokinski, M.M. Patnaik, B.R. Lewis, D.E. Grill, R.K. Pruthi, J.A. Heit
Issue: March 2016
Section: Original Article
Read on EJIM website

While Factor V Leiden (F5 rs6025 A allele) is a known venous thromboembolism (VTE) risk factor, VTE risk among heterozygous vs. homozygous carriers is uncertain.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness